Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Curr Cardiol Rep ; 26(9): 1021-1029, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-39052162

RESUMEN

PURPOSE OF REVIEW: In this review, we discuss the status of novel radiation shielding and other methods to reduce radiation exposure and its associated health risks within the CCL. RECENT FINDINGS: There are many devices on the market each with its unique advantages and inherent flaws. Several are available for widespread use with promising data, while others still in development. The field of percutaneous transcatheter interventions includes complex procedures often involving significant radiation exposure. Increased radiation exposes the proceduralist and CCL staff to potential harm from both direct effects of radiation but also from the ergonomic consequences of daily use of heavy personal protective equipment. Here we discuss several innovative efforts to reduce both radiation exposure and orthopedic injury within the CCL that are available, leading to a safer daily routine in a "lead [apron]-free" environment.


Asunto(s)
Cateterismo Cardíaco , Exposición Profesional , Exposición a la Radiación , Humanos , Cateterismo Cardíaco/métodos , Exposición Profesional/prevención & control , Exposición a la Radiación/prevención & control , Protección Radiológica/métodos , Protección Radiológica/instrumentación , Equipo de Protección Personal , Ropa de Protección
2.
Int J Angiol ; 31(3): 166-178, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-36157094

RESUMEN

Heart failure with preserved ejection fraction (HFpEF) encompasses nearly half of heart failure (HF) worldwide, and still remains a poor prognostic indicator. It commonly coexists in patients with vascular disease and needs to be recognized and managed appropriately to reduce morbidity and mortality. Due to the heterogeneity of HFpEF as a disease process, targeted pharmacotherapy to this date has not shown a survival benefit among this population. This article serves as a comprehensive historical review focusing on the management of HFpEF by reviewing past, present, and future randomized controlled trials that attempt to uncover a therapeutic value. With a paradigm shift in the pathophysiology of HFpEF as an inflammatory, neurohormonal, and interstitial process, a phenotypic approach has increased in popularity focusing on the treatment of HFpEF as a systemic disease. This article also addresses common comorbidities associated with HFpEF as well as current and ongoing clinical trials looking to further elucidate such links.

3.
J Innov Card Rhythm Manag ; 12(8): 4649-4656, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34476118

RESUMEN

This unique case highlights the electrophysiologic management and risk assessment of sudden cardiac death in a 35-year-old woman with a history of D-transposition of the great arteries status post-Mustard atrial switch repair.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA